A “failed experiment” of investing public money in risky biotech-style businesses cost Welsh taxpayers at least £28m but achieved all of its original objectives, a committee heard. Giles Thorley, who ...

Understand the implications of proposed changes to cancer services performance targets. What does it mean for patients?